Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.72B |
| 2 |
Apple
AAPL
|
+$1.98B |
| 3 |
Microsoft
MSFT
|
+$1.42B |
| 4 |
Alibaba
BABA
|
+$1.03B |
| 5 |
Amazon
AMZN
|
+$924M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$261M |
| 2 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$241M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$234M |
| 4 |
Keurig Dr Pepper
KDP
|
+$173M |
| 5 |
FedEx
FDX
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 50.21% |
| 2 | Technology | 11.19% |
| 3 | Healthcare | 7.18% |
| 4 | Consumer Discretionary | 7.09% |
| 5 | Financials | 5.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
CALL
Stellantis
STLA
$20.4B
| $4.52M | ﹤0.01% |
250,000
+100,000
| +67% | +$1.47M |
|
|
DFNS.WS
2502
CALL
DELISTED
LGL Systems Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for shares of Clas
DFNS.WS
| $4.52M | ﹤0.01% |
446,484
+152,548
| +52% | +$181K |
|
2503
Gerdau
GGB
$8.99B
| $4.51M | ﹤0.01% |
1,215,841
-1,899,136
| -61% | -$6.33M |
|
2504
Arcutis Biotherapeutics
ARQT
$3.04B
| $4.5M | ﹤0.01% |
160,094
+129,452
| +422% | +$3.17M |
|
2505
CoreCivic
CXW
$3.39B
| $4.5M | ﹤0.01% |
686,533
+428,694
| +166% | +$3.08M |
|
2506
Hims & Hers Health
HIMS
$6.92B
| $4.49M | ﹤0.01% |
307,230
-442,770
| -59% | -$4.92M |
|
2507
Schwab Short-Term US Treasury ETF
SCHO
$13B
| $4.49M | ﹤0.01% |
174,598
-83,908
| -32% | -$2.16M |
|
2508
Workhorse Group
WKHS
$34.4M
| $4.48M | ﹤0.01% |
76
-24
| -24% | -$1.56M |
|
|
ETACU
2509
DELISTED
E.Merge Technology Acquisition Corp. Unit
ETACU
| $4.48M | ﹤0.01% |
420,502
-709,998
| -63% | -$7.23M |
|
2510
Portland General Electric
POR
$5.89B
| $4.47M | ﹤0.01% |
104,613
-961,653
| -90% | -$39.2M |
|
2511
PUT
Clorox
CLX
$12.6B
| $4.46M | ﹤0.01% |
22,100
| – | – |
|
2512
RLI Corp
RLI
$5.94B
| $4.45M | ﹤0.01% |
85,408
-411,046
| -83% | -$19.7M |
|
2513
Kaiser Aluminum
KALU
$2.57B
| $4.43M | ﹤0.01% |
+44,767
| New | +$3.43M |
|
|
NTUS
2514
DELISTED
Natus Medical Inc
NTUS
| $4.43M | ﹤0.01% |
220,925
-47,494
| -18% | -$930K |
|
2515
Kiniksa Pharmaceuticals
KNSA
$6.14B
| $4.42M | ﹤0.01% |
250,394
-102,635
| -29% | -$1.8M |
|
|
NFJ
2516
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.45B
| $4.42M | ﹤0.01% |
+328,711
| New | +$4.14M |
|
2517
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.69B
| $4.42M | ﹤0.01% |
97,334
+92,343
| +1,850% | +$4.13M |
|
2518
Archrock
AROC
$5.58B
| $4.42M | ﹤0.01% |
510,065
-200,916
| -28% | -$1.47M |
|
2519
PUT
HCA Healthcare
HCA
$90.8B
| $4.39M | ﹤0.01% |
26,700
+19,600
| +276% | +$2.87M |
|
2520
Emergent Biosolutions
EBS
$310M
| $4.39M | ﹤0.01% |
48,974
-83,295
| -63% | -$7.64M |
|
2521
Warner Music
WMG
$14.7B
| $4.38M | ﹤0.01% |
115,276
+76,364
| +196% | +$2.33M |
|
|
HBI
2522
PUT
DELISTED
Hanesbrands
HBI
| $4.37M | ﹤0.01% |
+300,000
| New | +$4.53M |
|
2523
iShares Biotechnology ETF
IBB
$10.6B
| $4.37M | ﹤0.01% |
+28,870
| New | +$4.13M |
|
|
MKFG
2524
CALL
DELISTED
Markforged Holding Corporation
MKFG
| $4.37M | ﹤0.01% |
+40,560
| New | +$4.2M |
|
|
HEES
2525
DELISTED
H&E Equipment Services
HEES
| $4.37M | ﹤0.01% |
146,435
+31,727
| +28% | +$817K |
|
Similar funds
Israel Englander's Q4 2020 Portfolio in Review
As of Q4 2020, Israel Englander held 5,904 positions worth $138B, up 71% from $81.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $25B of net new capital in Q4 2020, opening 1,518 new positions and adding to 1,899 existing holdings. Its largest new stake was Sotera Health: 2,269,458 shares worth $62.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 52% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $173M trimmed.
- Israel Englander's largest Q4 2020 buy was Sotera Health: 2,269,458 shares worth $62.3M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $2.72B increase.
- Israel Englander's biggest Q4 2020 reduction was Keurig Dr Pepper, cutting an estimated $173M.
- Israel Englander fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $261M.
- Israel Englander's ten largest holdings make up 20% of its $138B portfolio in Q4 2020.
- Israel Englander opened 1,518 new positions and closed 754 in Q4 2020.
- Israel Englander's portfolio value rose 71% quarter-over-quarter to $138B.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.